Q2 2020

Filed Apr 13, 2020 · 10-Q · 44 days after period end · 0001683168-20-001154

Q2 2020 · 10-Q

Revenue

$1.31K

−43.5% vs Q2 2019

Net Income

-$867.87K

N/M vs Q2 2019

EPS Diluted

-$0.01

N/M vs Q2 2019

Operating Income-$866,368N/M

Operating Cash Flow

Same quarter

Metric	Q2 2020	Q2 2019	Q2 2015	Q2 2014
Revenue	$1.31K	$2.32K	$12.50K	$0.00
Net Income	-$867.87K	$3.73M	-$146.93K	-$55.35K
EPS Diluted	-$0.01	$0.07	-$0.00	$0.00

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

CNBX Pharmaceuticals Inc. · CIK 1343009 · Engraved from SEC EDGAR